UPV spin off receives one million euros for the development of ACORYS, a medical device designed to improve the effectiveness and treatment of Atrial Fibrillation.

Corify Care, a spin off company of the Polytechnic University of Valencia (UPV), has obtained a one million euros grant from the Research and Development Centre for Industrial Technology Development (CDTI) of the Spanish Ministry of Science and Innovation.

This grant will be destinated for the development of ACORYS, a medical device that, using technology created by the Hospital General Universitario Gregorio Marañón and the UPV, enhances the effectiveness and non-invasive treatment of atrial fibrillation, a cardiac arrhythmia that affects more than 10 million people just across Europe.

Related posts

Corify has achieved the ISO 13485 certification for its Quality Management System, this demonstrating our compromise with the development of high quality...

¡El pasado viernes 29 de septiembre fue el día mundial del corazón! Y que mejor forma de celebrarlo que compartiendo uno de...

Since November 2022, Corify Care is leading the CARE-ECGI project (Cardiac resynchronization therapy based on electrocardiographic image) funded by the Spanish Ministry...